Clinical Trial Update: RATIO: Rational Approach To Immuno-Oncology [NA]

View source ↗

Summary

A clinical trial update for the RATIO study on immuno-oncology in metastatic melanoma indicates the trial status is completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Melanoma

Snippet

Sponsor: AHS Cancer Control Alberta | Conditions: Metastatic Melanoma | NA | Status: COMPLETED